Pfizer-BioNTech vaccine effectiveness against Sars-Cov-2 infection: Findings from a large observational study in Israel.

Authors:
Saciuk Y; Kertes J; Mandel M; Hemo B; Shamir Stein N and 1 more

Journal:
Prev Med

Publication Year: 2021

DOI:
10.1016/j.ypmed.2021.106947

PMCID:
PMC8717697

PMID:
34974072

Journal Information

Full Title: Prev Med

Abbreviation: Prev Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Public Health

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Funding and disclosure of conflict of interest No formal funding or conflict of interest to report. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The study was carried out (sponsored) on behalf of Maccabi HealthCare Services for the purposes of evaluating the effectiveness of the vaccine among its members. The sponsor had no role in the study design, collection, analysis and interpretation of the data, writing of the article or decision to submit the report for publication."

Evidence found in paper:

"Funding and disclosure of conflict of interest"

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025